Multimedia | VHL Regional Portal

Resources found: 10

SP conclui vacinação de profissionais da segurança, ainda esta semana

Date: 14/02/2021

Saiba mais em www.vacinaja.sp.gov.br
See more details

Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Immunization Programs/organization & administration, Pandemics/prevention & control, Viral Vaccines/immunology, Risk Groups, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech, Profissionais da segurança

Vacinação do grupo de 65 e 66 anos em SP

Date: 07/04/2021

Saiba mais em www.vacinaja.sp.gov.br
See more details

Risk Groups, Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Immunization Programs/organization & administration, Viral Vaccines/supply & distribution, Aged, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech

Por que não vacinar primeiro os jovens, grupo que mais transmite o vírus?

Date: 13/01/2021

Saiba mais em www.saopaulo.sp.gov.br/coronavirus/vacina
See more details

Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/immunology, Risk Groups, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech

SP distribui 501 mil vacinas da Fiocruz

Date: 26/01/2021

Saiba mais em www.vacinaja.sp.gov.br
See more details

Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Risk Groups, COVID-19, Plano São Paulo, Vacina de Oxford, Fiocruz, Astrazeneca

Como foi a escolha do público alvo para vacinação?

Date: 08/12/2020

Saiba mais em www.saopaulo.sp.gov.br/coronavirus/vacina
See more details

Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Risk Groups, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech

Qual o público alvo da vacinação?

Date: 07/12/2020

Saiba mais em www.saopaulo.sp.gov.br/coronavirus/vacina
See more details

Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/immunology, Risk Groups, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech

Quais serão os primeiros grupos a receber a Coronavac?

Date: 19/10/2020

Saiba mais em www.saopaulo.sp.gov.br/coronavirus/vacina
See more details

Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/immunology, Risk Groups, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech

Quais serão os primeiros grupos a tomar a Coronavac?

Date: 24/09/2020

Saiba mais em: www.saopaulo.sp.gov.br/coronavirus/planosp
See more details

Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/immunology, Risk Groups, COVID-19, Plano São Paulo, Coronavac

Coronavac será para brasileiros

Date: 23/08/2020

Saiba mais em: www.saopaulo.sp.gov.br/coronavirus/planosp
See more details

Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/immunology, Public-Private Sector Partnerships/organization & administration, Risk Groups, COVID-19, Plano São Paulo, Coronavac , Instituto Butantan, Sinovac Biotech

Coronavírus: por que maiores de 60 anos não participam dos testes da vacina?

Date: 30/07/2020

Saiba mais em www.saopaulo.sp.gov.br/coronavirus/vacina
See more details

Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Healthy Volunteers, Aged, Risk Groups, COVID-19, Coronavac, Instituto Butantan, Sinovac Biotech, Plano São Paulo